Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: A Southwest oncology group phase II study, SWOG 9019
Kathy S. Albain, John J. Crowley, Andrew T. Turrisi, David R. Gandara, William B. Farrar, Joseph I. Clark, Kristie R. Beasley, Robert B. Livingston
Dive into the research topics of 'Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: A Southwest oncology group phase II study, SWOG 9019'. Together they form a unique fingerprint.